Exhibit 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Quarterly Report of Elite Pharmaceuticals, Inc.
(the "Company") on Form 10-Q for the quarter ended June 30, 2003 filed with the
Securities and Exchange Commission (the "Report"), I, Bernard Berk, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



         (1)  The Report fully complies with the requirements of Section 13(a)
         of the Securities Exchange Act of 1934; and

         (2)  The information contained in the Report fairly presents, in all
         material respects, the consolidated financial condition of the Company
         as of the dates presented and the consolidated result of operations of
         the Company for the periods presented.



                                               /s/ Bernard Berk
Date: August 13, 2003                     --------------------------------------
                                               Bernard Berk
                                               Chief Executive Officer of
                                               Elite Pharmaceuticals, Inc.


This certification has been furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed original of this written statement required by Section 906 has been
provided to Elite Pharmaceuticals, Inc. and will be retained by Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.